Novel Mefenamic Acid Analogs Featuring 4-Thiazolidinone Moiety: Design, Synthesis, In Silico Modeling and Biological Evaluation

Badrzadeh Shekarab, Arefeh; Gharahchoulou, Niloofar; Banisadr, Seyed Sam; Bayanati, Maryam; Mahboubi-Rabbani, Mohammad; Ketabforoosh, Shima H.M.E; Azizian, Homa; Almasirad, Ali

doi:10.48309/jaoc.2024.440607.1162

Articles in Press

Document Type : Original Article

Authors

¹ Department of Medicinal Chemistry, Faculty of Pharmacy, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran

² Department of Food Technology Research, National Nutrition and Food Technology Research Institute, Shahid Beheshti University of Medical Sciences, Tehran, Iran

³ Department of Medicinal Chemistry, School of Pharmacy, Alborz University of Medical Sciences, Karaj, Iran

⁴ Department of Medicinal Chemistry, School of Pharmacy, Iran University of Medical Science, Tehran, Iran

https://doi.org/10.48309/jaoc.2024.440607.1162

Abstract

In this work, a novel series of mefenamic acid analogs were developed and synthesized with the goal of developing a lead chemical that has anti-inflammatory efficacy and avoids the adverse effects of NSAIDs. Molecular docking analysis was performed by recruiting the ligands, COX-1 and COX-2 to identify the best-fitted molecule using AutoDock software. Afterwards, the compounds were synthesized and analyzed. To assess the drug's efficacy, the compounds were subjected to in vivo analgesic and anti-inflammatory experiments. Most of synthesized ligands have greater binding free energy than mefenamic acid on COX-1. When compared to the positive control, the compounds 2-(2,3-dimethylphenylamino)-N-(2-(3,5-di-tert-butyl-4-hydroxyphenyl)-4-oxothiazolidin-3-yl) benzamide, 2-(2,3-dimethylphenylamino)-N-(2-(4-fluorophenyl)-4-oxothiazolidin-3-yl)benzamide, 2-(2, 3-dimethylphenylamino)-N-(4-oxo-2-p-tolylthiazolidin-3-yl) benzamide and 2-(2,3-dimethylphenylamino)-N-(2-(4-chlorophenyl)-4-oxothiazolidin-3-yl) benzamide, 2-(2,3-dimethylphenylamino)-N-(2-(4-nitrophenyl)-4-oxothiazolidin-3-yl)benzamide demonstrated a larger or comparable proportion of analgesic and anti-inflammatory action respectively. Furthermore, the selected compounds “2-(2,3-dimethylphenylamino)-N-(2-(3,5-di-tert-butyl-4-hydroxyphenyl)-4-oxothiazolidin-3-yl) benzamide”, and “2-(2,3-dimethylphenylamino)-N-(4-oxo-2-p-tolylthiazolidin-3-yl) benzamide” seemed to have the least ulcerogenic activity. These findings show that some of the newly created mefenamic acid analogs may be selected as lead compounds due to their significant biological properties without ulcerogenic activity.

Graphical Abstract

Keywords

Main Subjects

References

[1]. M. Abdel-Tawab, H. Zettl, M. Schubert-Zsilavecz, Nonsteroidal anti-inflammatory drugs: a critical review on current concepts applied to reduce gastrointestinal toxicity, Current Medicinal Chemistry, 2009, 16, 2042-2063. [Crossref], [Google Scholar], [Publisher]

[2]. H.A. Al-Haboubi, I.J. Zeitlin, Re-appraisal of the role of histamine in carrageenan-induced paw oedema, European Journal of Pharmacology, 1983, 88, 169-176. [Crossref], [Google Scholar], [Publisher]

[3]. A. Almasirad, M. Tajik, D. Bakhtiari, A. Shafiee, M. Abdollahi, M.J. Zamani, R. Khorasani, H. Esmaily, Synthesis and analgesic activity of N-arylhydrazone derivatives of mefenamic acid, Journal of Pharmaceutical Sciences, 2005, 8, 419-425. [Crossref], [Google Scholar]

[4]. A. Almasirad, A. Shafiee, M. Abdollahi, A. Noeparast, N. Shahrokhinejad, N. Vousooghi, S.A. Tabatabai, R. Khorasani, Synthesis and analgesic activity of new 1, 3, 4-oxadiazoles and 1, 2, 4-triazoles, Medicinal Chemistry Research, 2011, 20, 435-442. [Crossref], [Google Scholar], [Publisher]

[5]. G. Sharma, S.B. Sharma, Synthetic Impatienol analogues as potential cyclooxygenase-2 inhibitors: A preliminary study, Journal of Applied Organometallic Chemistry, 2021, 1, 66-75. [Crossref], [Google Scholar], [Publisher]

[6]. A. Almasirad, S. Samiee-Sadr, A. Shafiee, Synthesis and antimycobacterial activity of 2-(Phenylthio) benzoylarylhydrazone derivatives, Iranian Journal of Pharmaceutical Research, 2011, 10, 727-731. [Google Scholar], [Publisher]

[7]. A. Almasirad, Z. Mousavi, M. Tajik, M.J. Assarzadeh, A. Shafiee, Synthesis, analgesic and anti-inflammatory activities of new methyl-imidazolyl-1, 3, 4-oxadiazoles and 1, 2, 4-triazoles, Daru Journal of Pharmaceutical Sciences, 2014, 22, 1-8. [Crossref], [Google Scholar], [Publisher]

[8]. A. Almasirad, P.S.V. Sani, Z. Mousavi, G.B. Fard, T. Anvari, M. Farhadi, M. Vosooghi, H. Azizian, Novel thiazolotriazolone derivatives: design, synthesis, in silico investigation, analgesic and anti‐inflammatory activity, Chemistry Select, 2022, 7, e202103228. [Crossref], [Google Scholar], [Publisher]

[9]. M. Amir, S.A. Javed, H. Kumar, Design and synthesis of 3-[3-(substituted phenyl)-4-piperidin-1-ylmethyl/-4-morpholin-4-ylmethyl-4, 5-dihydro-isoxazol-5-yl]-1 H-indoles as potent anti-inflammatory agents, Medicinal Chemistry Research, 2010, 19, 299-310. [Crossref], [Google Scholar], [Publisher]

[10]. S. Bindu, S. Mazumder, U. Bandyopadhyay, Non-steroidal anti-inflammatory drugs (NSAIDs) and organ damage: A current perspective, Biochemical Pharmacology, 2020, 180, 114147. [Crossref], [Google Scholar], [Publisher]

[11]. A.M. Brown, A new software for carrying out one-way ANOVA post hoc tests, Computer Methods and Programs in Biomedicine, 2005, 79, 89-95. [Crossref], [Google Scholar], [Publisher]

[12]. V. Cioli, S. Putzolu, V. Rossi, P.S. Barcellona, C. Corradino, The role of direct tissue contact in the production of gastrointestinal ulcers by anti-inflammatory drugs in rats, Toxicology and Applied Pharmacology, 1979, 50, 283-289. [Crossref], [Google Scholar], [Publisher]

[13]. M. Fernández, J. Caballero, QSAR modeling of matrix metalloproteinase inhibition by N- hydroxy-α-phenylsulfonylacetamide derivatives, Bioorganic & Medicinal Chemistry, 2007, 15, 6298-6310. [Crossref], [Google Scholar], [Publisher]

[14]. J.M. Figueiredo, C. de A Câmara, E.G. Amarante, A.L.P. Miranda, F.M. Santos, C.R. Rodrigues, C.A.M. Fraga, E.J. Barreiro, Design and synthesis of novel potent antinociceptive agents: methyl-imidazolyl N-acylhydrazone derivatives, Bioorganic & Medicinal Chemistry, 2000, 8, 2243-2248. [Crossref], [Google Scholar], [Publisher]

[15]. L.C. Gerstenfeld, M. Thiede, K. Seibert, C. Mielke, D. Phippard, B. Svagr, D. Cullinane, T.A. Einhorn, Differential inhibition of fracture healing by non‐selective and cyclooxygenase‐2 selective non‐steroidal anti‐inflammatory drugs, Journal of Orthopaedic Research, 2003, 21, 670-675. [Crossref], [Google Scholar], [Publisher]

[16]. A.A. Geronikaki, A.A. Lagunin, D.I. Hadjipavlou-Litina, P.T. Eleftheriou, D.A. Filimonov, V.V. Poroikov, I. Alam, A.K. Saxena, Computer-aided discovery of anti-inflammatory thiazolidinones with dual cyclooxygenase/lipoxygenase inhibition, Journal of Medicinal Chemistry, 2008, 51, 1601-1609. [Crossref], [Google Scholar], [Publisher]

[17]. M.M. Hanna, New pyrimido [5, 4-e] pyrrolo [1, 2-c] pyrimidines: Synthesis, 2D-QSAR, anti-inflammatory, analgesic and ulcerogenicity studies, European Journal of Medicinal Chemistry, 2012, 55, 12-22. [Crossref], [Google Scholar], [Publisher]

[18]. D. Kadam, S. Patil, D. Mammen, S. Kadam, V. More, In silico molecular docking against-KIT Tyrosine Kinase and ADME studies of 4-thiazolidinone derivatives, Journal of Applied Organometallic Chemistry, 2023, 3, 13-27. [Crossref], [Google Scholar], [Publisher]

[19]. M.N. Koopaei, M.J. Assarzadeh, A. Almasirad, S.F. Ghasemi-Niri, M. Amini, A. Kebriaeezadeh, N.N. Koopaei, M. Ghadimi, A. Tabei, Synthesis and analgesic activity of novel hydrazide and hydrazine derivatives, Iranian Journal of Pharmaceutical Research, 2013, 12, 721-727. [Crossref], [Google Scholar], [Publisher]

[20]. M. Khoshneviszadeh, N. Edraki, R. Miri, B. Hemmateenejad, Exploring QSAR for substituted 2‐sulfonyl‐phenyl‐indol derivatives as potent and selective COX‐2 inhibitors using different chemometrics tools, Chemical Biology & Drug Design, 2008, 72, 564-574. [Crossref], [Google Scholar], [Publisher]

[21]. S.H.E. Ketabforoosh, M. Amini, M. Vosooghi, A. Shafiee, E. Azizi, F. Kobarfard, Synthesis, evaluation of anticancer activity and QSAR study of heterocyclic esters of caffeic acid, Iranian Journal of Pharmaceutical Research, 2013, 12, 705. [Google Scholar], [Publisher]

[22]. D. Laxmi, S. Priyadarshy, HyperChem 6.03, Biotech Software & Internet Report: The Computer Software Journal for Scientists, 2002, 3, 5-9. [Crossref], [Google Scholar], [Publisher]

[23]. K. Meirer, D. Steinhilber, E. Proschak, Inhibitors of the arachidonic acid cascade: interfering with multiple pathways, Basic & Clinical Pharmacology & Toxicology, 2014, 114, 83-91. [Crossref], [Google Scholar], [Publisher]

[24]. M. Mahboubi-Rabbani, A. Zarghi, Dual human carbonic anhydrase/cyclooxygenase-2 inhibitors: A promising approach for cancer treatment, Anti-Cancer Agents in Medicinal Chemistry, 2021, 21, 2163-2180. [Crossref], [Google Scholar], [Publisher]

[25]. M. Mahboubi-Rabbani, M. Abbasi, A. Zarghi, Natural-derived COX-2 inhibitors as anticancer drugs: A review of their structural diversity and mechanism of action, Anti-Cancer Agents in Medicinal Chemistry, 2023, 23, 15-36. [Crossref], [Google Scholar], [Publisher]

[26]. M. Mahboubi-Rabbani, A. Zarghi, Selective COX-2 inhibitors as anticancer agents: A patent review (2014-2018), Expert Opinion on Therapeutic Patents, 2019, 29, 1-21. [Crossref], [Google Scholar], [Publisher]

[27]. M. Mahboubi-Rabbani, A. Zarghi, Lipoxygenase inhibitors as cancer chemopreventives: Discovery, recent developments and future perspectives, Current Medicinal Chemistry, 2021, 28, 1143-1175. [Crossref], [Google Scholar], [Publisher]

[28]. G.M. Morris, D.S. Goodsell, R.S. Halliday, R. Huey, W.E. Hart, R.K. Belew, A.J. Olson, Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function, Journal of Computational Chemistry, 1998, 19, 1639-1662. [Crossref], [Google Scholar], [Publisher]

[29]. T. Previtera, M. Vigorita, M. Basile, G. Fenech, A. Trovato, F. Occhiuto, M. Monforte, R. Barbera, 3, 3′-di (1, 3-thiazolidine-4-one) system. V. Synthesis and pharmacological properties of 3, 3′(1, 2-ethanediyl) bis-(2-heteroaryl-1, 3-thiazolidine-4-one) derivatives, European Journal of Medicinal Chemistry, 1990, 25, 569-579. [Crossref], [Google Scholar], [Publisher]

[30]. H. Al-Madhagi, Empowering therapeutic strategies against methicillin-resistant staphylococcus aureus riboswitch: Unveiling the potential of small molecules and antisense oligonucleotides through in silico analysis, Advanced Journal of Chemistry, Section A, 2024, 7, 15-26. [Crossref], [Google Scholar], [Publisher]

[31]. A.A. Rad, M. Sheikhha, R. Hosseini, S.A. Tabatabaic, A. Shafiee, Synthesis and Morphine Enhancement Activity of N‐[5‐(2‐phenoxyphenyl)‐1, 3, 4‐oxadiazole‐2‐yl]‐N′‐phenylurea derivatives, Archiv der Pharmazie: An International Journal Pharmaceutical and Medicinal Chemistry, 2004, 337, 193-200. [Crossref], [Google Scholar], [Publisher]

[32]. L.S. Simon, Role and regulation of cyclooxygenase-2 during inflammation, The American Journal of Medicine, 1999, 106, 37S-42S. [Crossref], [Google Scholar], [Publisher]

[33]. R. Todeschini, P. Gramatica, The WHIM theory: New 3D molecular descriptors for QSAR in environmental modelling, SAR and QSAR in Environmental Research, 1997, 7, 89-115. [Crossref], [Google Scholar], [Publisher]

[34]. R. Todeschini, P. Gramatica, SD‐modelling and prediction by WHIM descriptors. Part 5. Theory development and chemical meaning of WHIM descriptors, Quantitative Structure‐Activity Relationships, 1997, 16, 113-119. [Crossref], [Google Scholar], [Publisher]

[35]. A. John, A. Ebune, I. Aderemi, A. Moyosore, G. Idah, Theoretical investigation and design of novel anti-proliferative agents against hepatocellular carcinoma from benzimidazole-chalcone derivatives, Advanced Journal of Chemistry, Section A, 2023, 6, 92-104. [Crossref], [Google Scholar], [Publisher]

[36]. K. Aminu, A. Uzairu, S. Abechi, G. Adamu, A. Umar, A search for novel antidiabetic agents using ligand-based drug design and molecular docking studies employing human intestinal maltase-glucoamylase as model enzyme, Advanced Journal of Chemistry, Section A, 2023, 6, 155-171. [Crossref], [Google Scholar], [Publisher]

[37]. O. Trott, A.J. Olson, AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading, Journal of Computational Chemistry, 2010, 31, 455-461. [Crossref], [Google Scholar], [Publisher]

[38]. M. Vigorita, R. Ottanà, F. Monforte, R. Maccari, M. Monforte, A. Trovato, M. Taviano, N. Miceli, G. De Luca, S. Alcaro, Chiral 3, 3′-(1, 2-ethanediyl)-bis [2-(3, 4-dimethoxyphenyl)-4-thiazolidinones] with anti-inflammatory activity. Part 11: Evaluation of COX-2 selectivity and modelling, Bioorganic & Medicinal Chemistry, 2003, 11, 999-1006. [Crossref], [Google Scholar], [Publisher]

[39]. F. Ugbe, G. Shallangwa, A. Uzairu, I. Abdulkadir, A 2-D QSAR modeling, molecular docking study and design of 2-arylbenzimidazole derivatives as novel leishmania inhibitors: A molecular dynamics study, Advanced Journal of Chemistry, Section A, 2023, 6, 50-64. [Crossref], [Google Scholar], [Publisher]

[40]. A. Verma, S.K. Saraf, 4-Thiazolidinone–A biologically active scaffold, European Journal of Medicinal Chemistry, 2008, 43, 897-905. [Crossref], [Google Scholar], [Publisher]

[41]. J.L. Wallace, Distribution and expression of cyclooxygenase (COX) isoenzymes, their physiological roles, and the categorization of nonsteroidal anti-inflammatory drugs (NSAIDs), The American Journal of Medicine, 1999, 107, 11-16. [Crossref], [Google Scholar], [Publisher]

[42]. B. Whittle, The use of changes in capillary permeability in mice to distinguish between narcotic and nonnarcotic analgesics, British Journal of Pharmacology and Chemotherapy, 1964, 22, 246-253. [Crossref], [Google Scholar], [Publisher]

Novel Mefenamic Acid Analogs Featuring 4-Thiazolidinone Moiety: Design, Synthesis, In Silico Modeling and Biological Evaluation

References

References

Articles in Press, Accepted Manuscript Available Online from 02 April 2024

Articles in Press, Accepted Manuscript
Available Online from 02 April 2024